Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US
Tóm tắt
Từ khóa
Tài liệu tham khảo
Engels, 2011, Spectrum of cancer risk among US solid organ transplant recipients., JAMA, 306, 1891, 10.1001/jama.2011.1592
Grulich, 2007, Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis., Lancet, 370, 59, 10.1016/S0140-6736(07)61050-2
Sargen, 2020, Ambient ultraviolet radiation and sebaceous carcinoma incidence in the United States, 2000-2016., J Natl Cancer Inst Cancer Spectr, 4
Armstrong, 2001, The epidemiology of UV induced skin cancer., J Photochem Photobiol B, 63, 8, 10.1016/S1011-1344(01)00198-1
Jiyad, 2016, Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis., Am J Transplant, 16, 3490, 10.1111/ajt.13863
Casper, 2016, Infection-related cancers: prioritising an important and eliminable contributor to the global cancer burden., Lancet Glob Health, 4, e580, 10.1016/S2214-109X(16)30169-3
Robbins, 2015, Melanoma risk and survival among organ transplant recipients., J Invest Dermatol, 135, 2657, 10.1038/jid.2015.312
O’Reilly Zwald, 2011, Skin cancer in solid organ transplant recipients: advances in therapy and management: part II: management of skin cancer in solid organ transplant recipients., J Am Acad Dermatol, 65, 263, 10.1016/j.jaad.2010.11.063
Krynitz, 2013, Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008: a Swedish population-based study., Int J Cancer, 132, 1429, 10.1002/ijc.27765
Clarke, 2015, Risk of Merkel cell carcinoma after solid organ transplantation., J Natl Cancer Inst, 107, 10.1093/jnci/dju382
D’Arcy, 2021, Risk of rare cancers among solid organ transplant recipients., J Natl Cancer Inst, 113, 199
Sargen, 2020, Sebaceous carcinoma incidence and survival among solid organ transplant recipients in the United States, 1987-2017., JAMA Dermatol, 156, 1307, 10.1001/jamadermatol.2020.3111
Cahoon, 2018, Risk of Kaposi sarcoma after solid organ transplantation in the United States., Int J Cancer, 143, 2741, 10.1002/ijc.v143.11
Garrett, 2016, Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013., J Am Acad Dermatol, 75, 106, 10.1016/j.jaad.2016.02.1155
Ribas, 2018, Cancer immunotherapy using checkpoint blockade., Science, 359, 1350, 10.1126/science.aar4060
d’Izarny-Gargas, 2020, Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: a systematic review., Am J Transplant, 20, 2457, 10.1111/ajt.v20.9
Abdel-Wahab, 2019, Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature., J Immunother Cancer, 7, 106, 10.1186/s40425-019-0585-1
Benoni, 2020, Survival among solid organ transplant recipients diagnosed with cancer compared to nontransplanted cancer patients: a nationwide study., Int J Cancer, 146, 682, 10.1002/ijc.v146.3
Noone, 2019, Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014., Cancer, 125, 2647, 10.1002/cncr.32136
Chaturvedi, 2008, Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers., Ann Epidemiol, 18, 230, 10.1016/j.annepidem.2007.10.005
D’Arcy, 2020, Voriconazole and the risk of keratinocyte carcinomas among lung transplant recipients in the United States., JAMA Dermatol, 156, 772, 10.1001/jamadermatol.2020.1141
Zamoiski, 2017, Risk of second malignancies in solid organ transplant recipients who develop keratinocyte cancers., Cancer Res, 77, 4196, 10.1158/0008-5472.CAN-16-3291
Sargen, 2020, Variation in cutaneous patterns of melanomagenesis according to germline CDKN2A/CDK4 status in melanoma-prone families., J Invest Dermatol, 140, 174, 10.1016/j.jid.2019.06.138
Seçkin, 2013, Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series., Am J Transplant, 13, 2146, 10.1111/ajt.12281
Swerdlow, 2007, T-cell and NK-cell posttransplantation lymphoproliferative disorders., Am J Clin Pathol, 127, 887, 10.1309/LYXN3RGF7D7KPYG0
Moore, 2010, Why do viruses cause cancer? Highlights of the first century of human tumour virology., Nat Rev Cancer, 10, 878, 10.1038/nrc2961
Sargen, 2021, Sebaceous carcinoma epidemiology and genetics: emerging concepts and clinical implications for screening, prevention, and treatment., Clin Cancer Res, 27, 389, 10.1158/1078-0432.CCR-20-2473
Tetzlaff, 2019, Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through nonoverlapping molecular-genetic alterations., Clin Cancer Res, 25, 1280, 10.1158/1078-0432.CCR-18-1688
Kesserwan, 2012, Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency., J Allergy Clin Immunol, 129, 762, 10.1016/j.jaci.2011.10.028
Allais, 2021, Five-year survival in patients with nodular and superficial spreading melanomas in the US population., J Am Acad Dermatol, 84, 1015, 10.1016/j.jaad.2020.11.047
Thomas, 2014, Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study., JAMA Dermatol, 150, 1306, 10.1001/jamadermatol.2014.1348
Yarchoan, 2017, Tumor mutational burden and response rate to PD-1 inhibition., N Engl J Med, 377, 2500, 10.1056/NEJMc1713444
Hernando, 2021, The effect of age on the acquisition and selection of cancer driver mutations in sun-exposed normal skin., Ann Oncol, 32, 412, 10.1016/j.annonc.2020.11.023
Riva, 2012, How I treat HHV8/KSHV-related diseases in posttransplant patients., Blood, 120, 4150, 10.1182/blood-2012-04-421412
Copeland, 2021, Fatal donor-derived Kaposi sarcoma following liver transplantation., BMJ Case Rep, 14, 10.1136/bcr-2020-236061
Guiguet, 2009, Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study., Lancet Oncol, 10, 1152, 10.1016/S1470-2045(09)70282-7
Charlton, 2018, International liver transplantation society consensus statement on immunosuppression in liver transplant recipients., Transplantation, 102, 727, 10.1097/TP.0000000000002147
Pilch, 2021, Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management., Pharmacotherapy, 41, 119, 10.1002/phar.v41.1
Crow, 2019, Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines., Transpl Int, 32, 1268, 10.1111/tri.v32.12
Wang, 2021, Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma., Oncogene, 40, 5590, 10.1038/s41388-021-01911-5
Kwong, 2013, Navigating the therapeutic complexity of PI3K pathway inhibition in melanoma., Clin Cancer Res, 19, 5310, 10.1158/1078-0432.CCR-13-0142
Alvarez Orellana, 2021, Sirolimus and other mechanistic target of rapamycin inhibitors directly activate latent pathogenic human polyomavirus replication., J Infect Dis, 224, 1160, 10.1093/infdis/jiaa071
Nichols, 2011, Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug., PLoS One, 6, 10.1371/journal.pone.0014535
Stallone, 2005, Sirolimus for Kaposi’s sarcoma in renal-transplant recipients., N Engl J Med, 352, 1317, 10.1056/NEJMoa042831
Acuna, 2017, Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines., Am J Transplant, 17, 103, 10.1111/ajt.13978
Acuna, 2016, Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada., JAMA Oncol, 2, 463, 10.1001/jamaoncol.2015.5137
Chan, 2019, Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study., Am J Transplant, 19, 522, 10.1111/ajt.14966
Euvrard, 2012, Sirolimus and secondary skin-cancer prevention in kidney transplantation., N Engl J Med, 367, 329, 10.1056/NEJMoa1204166
Esfahani, 2019, Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation., Nat Commun, 10, 4712, 10.1038/s41467-019-12628-1
National Cancer Institute. Transplant Cancer Match Study. Accessed January 28, 2022. https://transplantmatch.cancer.gov/index.html
Surveillance, Epidemiology, and End Results Program. Registry Groupings in SEER Data and Statistics. 2021. Accessed September 15, 2021. https://seer.cancer.gov/registries/terms.html
National Aeronautics and Space Administration. TOMS Nimbus-7 Total Ozone Aerosol Index UV-Reflectivity UV-B Erythemal Irradiances Daily L3 Global 1 deg x 1.25 deg V008. Accessed January 28, 2022. https://disc.gsfc.nasa.gov/datasets/TOMSN7L3_008/summary